Romano Antonino, Gaeta Francesco, Valluzzi Rocco Luigi, Alonzi Cristiana, Viola Marinella, Bousquet Philippe Jean
Unità di Allergologia, Complesso Integrato Columbus, Via G. Moscati, 31, 00168 Rome, Italy.
Pediatrics. 2008 Sep;122(3):521-7. doi: 10.1542/peds.2007-3178.
The goals were to evaluate the usefulness of skin tests, patch tests, serum specific IgE assays, and challenges in diagnosing hypersensitivity reactions to cephalosporins and to clarify the pathogenic mechanism of such reactions.
Children with immediate manifestations (within 1 hour) underwent immediate-reading skin tests with penicillin reagents and any suspect cephalosporins, serum specific IgE assays, and challenges; some children underwent reevaluations. Children with nonimmediate manifestations (after >1 hour) were assessed with patch tests, delayed-reading skin tests, and challenges.
We evaluated 148 children with hypersensitivity reactions to cephalosporins, mainly cefaclor and ceftriaxone; 105 had experienced nonimmediate manifestations (mostly urticarial eruptions and maculopapular rashes) and 43 immediate manifestations (anaphylactic shock, urticaria and/or angioedema, and erythema). None of the nonimmediate reactors demonstrated positive results in patch tests and/or delayed skin tests; only 1 subject displayed immediate positive responses to penicillin skin-test reagents. Among the 104 patients with negative results, 96 underwent challenges; 95 tolerated the challenges, and 1 reacted to the cefaclor pediatric suspension and tolerated the challenge with a cefaclor capsule. In the first allergologic evaluation, 33 of the 43 children with immediate reactions displayed skin-test positivity. Of the 10 patients with negative results, 7 underwent challenges, followed by therapeutic courses and reevaluations for 4. All challenges and therapeutic courses were tolerated; in the reevaluation, 1 girl demonstrated positive skin-test results for both the responsible cephalosporin and penicillin reagents. Overall, IgE-mediated hypersensitivity was diagnosed for 34 (79%) of 43 subjects.
Extremely few nonimmediate manifestations associated with cephalosporin therapy are actually hypersensitivity reactions, whereas most immediate reactions to cephalosporins are IgE-mediated. Cephalosporin skin testing is a useful tool for evaluating such reactions.
本研究旨在评估皮肤试验、斑贴试验、血清特异性IgE检测以及激发试验在诊断头孢菌素过敏反应中的作用,并阐明此类反应的发病机制。
对出现速发症状(1小时内)的儿童进行青霉素试剂及任何可疑头孢菌素的即时读数皮肤试验、血清特异性IgE检测以及激发试验;部分儿童接受了重新评估。对出现迟发症状(1小时后)的儿童进行斑贴试验、延迟读数皮肤试验以及激发试验。
我们评估了148例对头孢菌素过敏反应的儿童,主要为头孢克洛和头孢曲松;105例出现迟发症状(主要为荨麻疹和斑丘疹),43例出现速发症状(过敏性休克、荨麻疹和/或血管性水肿以及红斑)。迟发反应者在斑贴试验和/或延迟皮肤试验中均未显示阳性结果;仅1例受试者对青霉素皮肤试验试剂呈速发阳性反应。在104例结果为阴性的患者中,96例接受了激发试验;95例耐受激发试验,1例对头孢克洛小儿混悬液有反应,但对头孢克洛胶囊激发试验耐受。在首次变态反应学评估中,43例速发反应儿童中有33例皮肤试验呈阳性。10例结果为阴性的患者中,7例接受了激发试验,随后4例接受了治疗疗程及重新评估。所有激发试验和治疗疗程均耐受;在重新评估中,1名女孩对致病头孢菌素和青霉素试剂的皮肤试验结果均呈阳性。总体而言,43例受试者中有34例(79%)被诊断为IgE介导的超敏反应。
与头孢菌素治疗相关的迟发症状极少为真正的过敏反应,而大多数头孢菌素速发反应为IgE介导。头孢菌素皮肤试验是评估此类反应的有用工具。